The Effects of Trans Venous Cardiac Pacing on Coronary Microvascular Function and Hemodynamics (NCT03917251) | Clinical Trial Compass
WithdrawnNot Applicable
The Effects of Trans Venous Cardiac Pacing on Coronary Microvascular Function and Hemodynamics
Stopped: PI left the institution
0Started 2021-10-07
Plain-language summary
The study will examine role of transvenous pacing on coronary microcirculation.
Who can participate
Age range19 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
All patients 19 years of age or older with clinical evidence of coronary ischemia undergoing coronary angiogram, and who have a pacemaker.
Exclusion Criteria:
* Acute ST segment myocardial infarction
* Known sensitivity or contraindication to the agents planned for administration during coronary angiography
* Pacemaker dependent patients
* Pregnancy
* Hypotension (a systolic blood pressure lower than 90mmHg) that would preclude the administration of adenosine
* Severe renal dysfunction, defined as a estimated glomerular filtration (eGFR) less than 30ml/min, confirmed by recent testing
* Study subject has any underlying disorder that, in the opinion of the investigator, precludes them from giving informed consent at the time of enrollment
What they're measuring
1
Patients that exhibit coronary microvascular resistance and dysfunction as reflected by FFR